The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin

The Ser/Thr kinase CK2 (former name: casein kinase 2) is a heterotetrameric enzyme composed of two catalytic chains (CK2 alpha) attached to a dimer of noncatalytic subunits. Together with the cyclin-dependent kinases and the mitogen-activated protein kinases, CK2 alpha belongs to the CMGC family of the eukaryotic protein kinases. CK2 is an important survival and stability factor in eukaryotic cells: its catalytic activity is elevated in a wide variety of tumors while its down-regulation can lead to apoptosis. Thus, CK2 is a valuable target for drug development and for chemical biology approaches of cell biological research, and small organic inhibitors addressing CK2 are of considerable interest. We describe here the complex structure between a C-terminal deletion mutant of human CK2 alpha and the ATP-competitive inhibitor emodin (1,3,8-trihydroxy-6-methylanthraquinone, International Union of Pure and Applied Chemistry name: 1,3,8-trihydroxy-6-methylanthracene-9,10-dione) and compare it with a previously published complex structure of emodin and maize CK2 alpha. With a resolution of 1.5 angstrom, the human CK2 alpha/emodin structure has a much better resolution than its maize counterpart (2.6 angstrom). Even more important, in spite of a sequence identity of more than 77% between human and maize CK2 alpha, the two structures deviate significantly in the orientation, in which emodin is trapped by the enzyme, and in the local conformations around the ligand binding site: maize CK2 alpha shows its largest adaptations in the ATP-binding loop, whereas human shows its largest adaptations in the hinge region connecting the two domains of the protein kinase core. These observations emphasize the of local plasticity for ligand binding and demonstrate that two orthologues of an enzyme can behave quite different in this respect. (c) 2008 Elsevier Ltd. All rights reserved.